![]() Abnormal Development and Teratology Birth defects are the leading cause of infant mortality and are responsible for substantial morbidity and disability. In addition, because programmed cell death has emerged as a common mechanistic step in many aspects of morphogenesis, two chapters are devoted to the methods of the analysis of apoptosis (Chapters 13 and 14). These systems exemplify the diversity of developmental mechanisms involved in organogenesis, as well as the experimental techniques applicable to their analysis. Practical details on a number of organ/tissue systems in vertebrates are presented, including mammary gland (Chapter 4), heart (Chapter 5), skeleton (craniofacial: Chapters 6 and 7 axial and appendicular, Chapter 8), limb (Chapter 9), thymus (Chapter 10), liver (Chapter 11), and skin (Chapter 12). Organogenesis Studies on Drosophila (Chapter 2) and Xenopus (Chapter 3) are first presented to illustrate the power of these systems for deciphering the experimental principles of developmental biology. ![]() The volume concludes with detailed description of the technologies used to identify developmentally important genes and the methods for transgenesis, including gene knockout. This second volume of the three-volume set begins by presenting the tissue and organ models currently being studied, and the characteristics of abnormal development. It is the goal of Developmental Biology Protocols to present to the readers a set of contemporary, practical experimental tools dealing with a wide-ranging spectrum of topics in developmental biology research. Introduction The discipline of developmental biology covers scientific investigations aimed at deciphering the underlying mechanisms responsible for diversity and order within tissues and organs. If you want to be part of the next chapter, contact us today.Developmental Biology Protocols Volume II Edited byĭevelopmental Biology Protocols: Overview IIġ Developmental Biology Protocols Overview II Rocky S. When it happens, Micromate™ users will also be able to achieve the same reported submillimeter accuracy under CT, Ultrasound, and/or Optical Navigation guidance. Over the next 9 months, along with installing more reference sites in Europe and expanding to other key geographies, we are going to launch our full-fledged surgical platform. Innovation is at the core of our strategy, as it is making our cutting-edge technology available everywhere, for as many applications as possible. The one-month follow-up appointments with the patients confirmed the successful outcomes. Several more surgeries took place since that day, all with 100% accuracy and no reported pedicle breach events. Integrated into the Fusion Robotics system – which also includes a navigation station and an instrument set – Micromate™ assisted on the execution of a single-level minimally invasive transforaminal lumbar interbody fusion (MI-TLIF), including the placement of pedicle screw fixation guided by the robot. Kevin Foley, at Baptist Memorial Hospital, in Memphis, TN, completed the first spine fusion procedure using Micromate™. This versatile, modular surgical platform was also adopted by strategic partners looking to support robotic-guided procedures for different applications. No complications have been reported, and a 100% diagnostic yield and accuracy have been attained on biopsy procedures.Ī modular surgical platform for minimally invasive surgery These results are based on reported data from procedures conducted in 10 body regions, some particularly critical: Femur, Liver, Thoracic Spine, Lumbar Spine, Aorta, Lung, Ovaries, Ilium-sacrum, Sternum, and the Parotid Gland. In the reported cases, Micromate™ supported 0.43 ± 0.5mm average accuracy of alignment to the trajectory and 0.79 ± 0.41º average angular accuracy of needle guidance from entry to target location. Quickly approaching 100 procedures, Micromate™ has confirmed its capability of supporting submillimeter accuracy from head to toe. Nine months have passed since that first installation, and the clinical results obtained with the system by the reference sites in The Netherlands, Austria, and Switzerland are remarkable. The highest accuracy with no complications Antonius Ziekenhuis, in Nieuwegein, The Netherlands. The first ever Micromate™ user has been Dr. In what has been an unusual year for the MedTech industry, Micromate™ performed substantially well: unveiled to the world in Spring 2020, it obtained its CE-Mark in early Summer, and started its clinical use in early Fall.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |